Recruiting Eligible Patients at U.S. Sites

A Phase 1 Study of Autologous Desmoglein 3 Chimeric Autoantibody Receptor T Cells (DSG3-CAART) in Mucosal Pemphigus Vulgaris, Sponsored by Cabaletta Bio, Inc.

Learn More About This Study

Clinical Trial Inquiries

Are you wondering if this clinical trial is right for you? A representative from our patient recruitment center would be glad to discuss the study with you. Alternatively, please email the Cabaletta Study Team.

Cabaletta Study Team:

Email: clinicaltrials@cabalettabio.com

Patient Recruitment Center Contact Information:

Phone: +1-800-711-4906

Email*: cabalettatrials@iqvia.com

*Please include only your name and telephone number in the email. Someone from the recruitment center will contact you to discuss the study.